The Tissue Modeling and Drug Development Core (TMDDC) provides a growing archive of fixed and living tissues, DNA, and RNA for sequencing to support the CaRE2 mission. We are also developing a robust, well-annotated biorepository of tissue samples from a racially and ethnically diverse Florida and California patient population and make them available to the CaRE2 investigators.
Together, the TMDDC leaders provide an unusual combination of synergistic skills and experiences ranging from highly technical pathological and research procedures to clinical therapeutics and from basic science to translational research to products to reduce cancer burden.
To request samples, you will need to submit specific information including proof of IRB approval, specific aims, statistical analysis, and detailed specimen information drawn from the above inventories.
Many resources are available to researchers outside the CaRE2 in-house tissue inventories. These include NCI-funded modeling projects and tissues collected as part of other research. Learn more about some of these resources and how to access them.
To request samples, you will need to submit specific information including proof of IRB approval, specific aims, statistical analysis, and detailed specimen information drawn from the above inventories.
If you share our interest in reducing cancer health disparities, please consider becoming a member of the CaRE² center. Investigators, trainees, community leaders, and advocates are welcome.
Stay up to date with the latest news and information about CaRE2
Have questions about working with the TMDDC? We’d love to hear from you. Please include any specific tissue type needs to allows us to better answer your question.